Most U.S. adults with type 2 diabetes (T2D) meet recommended criteria for use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs)
Month: February 2023
Eight-week bedaquiline-linezolid noninferior for TB
A strategy of eight weeks of bedaquiline-linezolid is noninferior to a standard regimen for tuberculosis, according to a study published
Study: To promote exercise, planners must look beyond cities
To encourage more active lifestyles, public health agencies recommend mixed-use neighborhoods and “complete” streets that are friendlier to walkers and
What experts wish more people knew about hospice and other end-of-life care
As soon as the news broke that 98-year-old former President Jimmy Carter had entered hospice care after many years of
Personal psychedelic use may be common among psychedelic therapists
Whether personal use of psychedelics is appropriate among psychedelic therapists, a new study finds that it may be common. The
Improving diagnosis of chronic lung, ear and sinus infections in young children
University of Southampton researchers have recommended a method to help diagnose preschool age children with Primary Ciliary Dyskinesia (PCD). PCD
Researchers use artificial intelligence to predict cardiovascular disease
Researchers may be able to predict cardiovascular disease—such as arterial fibrillation and heart failure—in patients by using artificial intelligence (AI)
AI tool may speed screening of epilepsy drugs in mice
By using state-of-the-art technology to analyze patterns of behavior in mice with epilepsy, researchers may be able to better study
Breast cancer-fighting gene’s job made more difficult by obesity
A new study published in Science Translational Medicine has found that in women with BRCA gene mutations, having a high body mass
Research team delivers a new first in heart failure treatment using cell therapy
Physician-scientists at The Texas Heart Institute announced today the results of the largest cell therapy trial to date in patients